Join our CEO, Colin Hill on the Aspen Ideas: Health Panel
We are thrilled to announce that Aitia will be participating in the highly anticipated Aspen Ideas: Health conference. Our CEO, Colin Hill, will be taking the stage on a thought-provoking panel titled “Open to Debate: Is the FDA too Cautious?” alongside distinguished panelist Peter Lurie, President and Executive Director of the Center for Science in […]
HD Therapeutics Conference Poster | Gemini Digital Twins Identified Both Common and Disease-specific Drivers of Cognitive Progression in Huntington’s and Alzheimer’s Diseases
L.Sun, S.Sathe, X.Shen, P.Ashrap, K.Johnson, S.Sukhram, S.Reddy, S-Y.Shin, J.Latourelle, C.Sampaio
World Congress: AI and Digital Twins to Drive the Next Generation Drug Discovery and Development
Watch Colin Hill’s talk at Charles River’s sixth Annual World Congress on May 11, 2023, in Cambridge, MA. Colin’s session focused on “Al and Digital Twins to Drive the Next Generation of Drug Discovery and Development”. The presentation was followed by a fireside chat with Julie Frearson, Chief Scientific Officer at Charles River Laboratories. This […]
Join Aitia at the Drug Discovery Europe & Neuroscience Drug Development Europe 2023 Conference in Berlin
We are thrilled to announce that our CBO, Joe Donahue will be taking the stage at the Drug Discovery Europe & Neuroscience Drug Development Europe 2023 Conference in Berlin, Germany. Session title: Digital Twins Unlock the Biological Complexity of Human Disease and Will Drive the Next Wave of Breakthrough Drugs Digital Twins are computational representations of […]
Servier Doubles Up on Digital Twin Alliance with Aitia
The new project will focus on pancreatic cancer, and builds on a collaboration in the blood cancer multiple myeloma that was started by the two companies last year. Read more on the latest collaboration between Servier and Aitia, in Pharmaphorum article. Full article here. Picture Credit: Pharmaphorum
Join Aitia at the Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine – AIPM 2023
Join us at the Symposium on Risks and Opportunities of AI in Pharmaceutical Medicine on June 5, sponsored by Pfizer Inc., the Roux Institute at Northeastern University, and the American Statistical Association (ASA). At Aitia, we are excited to present a session entitled “Causal AI for Learning ‘Digital Twins’ from Human Multi-Omic Data for Drug […]
Meet us at Bio-IT World Conference in Boston
We are thrilled to announce that Joe Donahue will be chairing a session entitled “Discover Novel Drug Candidates to Produce Better Precision Medicines” at the Bio-IT World Conference on May 18th at 10:20 ET, as part of the “AI for Drug Discovery and Development” track. The AI for Drug Discovery and Development track is an […]
Join Aitia at Charles River’s sixth Annual World Congress
We are excited to announce that Colin Hill will be speaking at Charles River’s sixth Annual World Congress on May 11, 2023, in Cambridge, MA. Colin’s session will focus on “Al and Digital Twins to Drive the Next Generation of Drug Discovery and Development”. The presentation will be followed by a fireside chat with Julie […]
AACR Poster | Infer Cancer Cell Gene Dependency in Multiple Myeloma Using Causal AI in-silico Patient Model
Brandon Nathasingh, Derek Walkama, Laurel Mayhew, Kendall Loh, Jeanne Latourelle, Bruce W Church, Yaoyu E Wang
Join Aitia and our Partner GAP at the American Academy of Neurology Annual Meeting 2023
We are excited to announce our attendance at the American Academy of Neurology Annual Meeting 2023, which will be held in Boston. As we look forward to this event, we are also pleased to be joined by our strategic partner the Global Alzheimer’s Platform Foundation (GAP). Together, we are committed to advancing the field of […]